MichaelMullanRoskamp.com Offers All Great Discoveries by Dr. Michael Mullen at Roskamp Institute
Sarasota, August 21, 2015 (Newswire.com) - There has been many scientific discoveries over the years but some of them have immense impact on human lives. One such discovery is the ways of addressing the dreaded Alzheimer’s disease and the pioneer of the discovery is one person in a singularly different institute.
Over the years Alzheimer’s diseases has been a paradox for both the patients as well as the physicians. Till date no conclusive medication or treatment had been invented to address the problems created by the disease that were as much psychological as were physical.
That was before Dr. Michael Mullan and his scientific collaborator Roskamp Institute intervened. Scientific discoveries that resulted due to combined efforts of these two are phenomenal. In the process, Mullan has been substantially added and assisted by Bob Roskamp the founder of the institute.
Dr. Michael Mullan himself is the Research Specialist in the Institute that is dedicated to finding effective solutions to all types of neurological problems faced by the patients. Especially targeted by the researcher and the institute is the Alzheimer’s disease that is neurologically degenerative. There is also a trend of providing funds for research on incurable diseases going for short term trials. Such diseases include HIV AIDS, cancer and of course; Alzheimer’s disease among others.
The trend is good for the entire world as it has resulted in some of the important discoveries. Some of these discoveries include early detection of diseases like cancer as well as medications that ensures higher lives for the people suffering from renal diseases. The Sarasota based institute, Roskamp is certainly ahead of most others in this regard, that is, in making inventions for addressing disease related issues. Once again the pioneer for them is Mullan.
One of the major contributions of Dr. Mullan has been that his work adds incredible values to the areas that are lowly funded globally. In the process he has come up with some real groundbreaking findings and effective treatment for the renal diseases.
“While around 5.4 million people in America are suffering from the dreaded disease; the number can easily go up to 16 million by the year 2050. Roskamp; a non-profit institute in Sarasota carries out studies in different renal diseases including the Alzheimer’s disease and aims at discovering effective drug therapies to address the disease related issues. This will help physicians all over the world devise successful treatments for the disease”, says Dr. Mullan.
“I believe that the elderly people are the most cherished population of the society who has contributed successfully to safety and security of the world. Working for their care as well as discovery of new treatments for this cherished population is our ultimate objective”, he concluded.
The aim is noble and the world is certainly going to benefit from it.
About Dr. Michael Mullan:
Dr. Micheael Mullan is researcher of Alzheimer’s disease and his also the member of the original research team that discovered genetic inaccuracies in patients leading to excess production of beta-amyloid. The discovery lead the research team in Roskamp Institute recognizes the potential of the therapeutic processes for treatment of the dreaded Alzheimer’s disease. For details,
http://www.dailymotion.com/video/x180vlp_michael-mullan_news .
-=====================
Contact Information:
Dr. Michael Mullan
CEO Rockcreek Pharmaceuticals
Sarasota, Florida, United States
Roskamp Institute, Sarasota.
Email id: michaelmullan@roskamp.com